The Next-Generation Sequencers (NGS) market is experiencing significant growth, driven by advancements in technology, decreasing sequencing costs, and the increasing use of genomic data in personalized medicine and research. This report provides insights into the market’s drivers, regional landscape, key players, and future projections.